Anne Beaven

University of North Carolina-Chapel Hill, NC

Associate Professor of Medicine, Vice Chief of Operations, Division of Hematology

Specialty Areas

Non-Hodgkin lymphoma, Hodgkin lymphoma, cutaneous T-cell lymphoma

Chronology

Bachelor of Arts: Wesleyan University, 1989-1993; MD: University of North Carolina at Chapel Hill, 1996 – 2000; Internal Medicine Resident: University of North Carolina-Chapel Hill, 2000-2003;  Internal Medicine Chief Resident: University of North Carolina-Chapel Hill, 2003-2004; Hematology-Oncology Fellowship: University of North Carolina-Chapel Hill, 2004-2007; Medical Instructor: Duke University, 2007-2008: Assistant Professor: Duke University, 2008-2013; Associate Professor: Duke University, 2013-2017; Medical Director of Inpatient Hematologic Malignancy Services: Duke University, 2015-2017; Associate Professor: University of North Carolina-Chapel Hill, 2017-present; Director of Lymphoma Program: University of North Carolina-Chapel Hill, 2017-present.

Research and Clinical Interests

Non-Hodgkin lymphoma, Hodgkin lymphoma, Cutaneous Lymphoma, Mycosis Fungoides, Sezary Syndrome; Chimeric Antigen Receptor T (CAR-T) cell therapy and clinical trials; Treatment of the older lymphoma patient

Personal Statement

My research and clinical work focus on the care of patients with all types of Hodgkin and non-Hodgkin lymphoma including cutaneous T-cell lymphomas (mycosis fungoides). This is a job I love. On my clinic days, I am fortunate to have the opportunity to see many wonderful patients and their families while working hard to help them through the difficult process of getting diagnosed and treated with cancer. Then, on the non-clinic days, I can use my intellectual side as I continue to work for my patients by conducting research to find ways to better treat and cure lymphoma.